comparemela.com

Latest Breaking News On - Rosanne welcher - Page 1 : comparemela.com

Santa Barbara software firm hits it out of the park at Ventech PitchFest

BridgeDoc founders Cameron Lyons, left, and Kelly Wheeler talking to the judges after their pitch. (Jorge Mercado / PCBT Staff) Hundreds of members from the Santa Barbara community from investors to business owners to curious parties packed into the Cabrillo Pavilion on April 18 to see five executives duke it out in the

Kelly-wheeler
Jason-spievak
Jorge-mercado
Jas-dhillon
Cameron-lyons
Dave-adornetto
Rosanne-welcher
Max-menke
Santa-barbara
Jorge-mercado-thursday
Cabrillo-pavilion

NXgenPort aims to detect early signs of infection in cancer patients before symptoms arise

Meet NXgenPort, a startup that’s looking to remotely monitor cancer patients in between doctors visits using a port catheter.

Minnesota
United-states
Saint-paul
Utah
Rosanne-welcher
Cathy-skinner
Edward-elmhurst-health-ventures
Techcrunch-disrupt-startup-battlefield
Edward-elmhurst-health

NXgenPort wins the TechCrunch Live Minneapolis pitch-off

NXgenPort wins the TechCrunch Live Minneapolis pitch-off
techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.

Rosanne-welcher
M-ali-mohamed
Cathy-skinner
Today-techcrunch
Techcrunch-live
Techcrunch-disrupt
Axon-athletics
Kyros-care

NXgenPort Announces Collaboration with Mayo Clinic

NXgenPort Announces Collaboration with Mayo Clinic News provided by Share this article Share this article MINNEAPOLIS and VENTURA, Calif., May 25, 2021 /PRNewswire/ NXgenPort, a biomedical technology company developing products to provide doctors with remote patient monitoring, announced today that it has entered into a license agreement with Mayo Clinic to advance development and product testing efforts.   NXgenPort s medical device helps providers like Mayo Clinic monitor cancer patients at home with an implantable chemo-port catheter (patent pending). NXgenPort combines proven chemo-port efficacy with sensor technology to measure and remotely monitor early onset of complications by reporting and tracking patient response over the course of their treatment. According to the Chief Science Officer at NXgenPort, Dr. Rosanne Welcher, NXgenPort will bring the benefits of remote patient monitoring to cancer patients, who may have limited support between their trea

Rosanne-welcher
Prnewswire-nxgenport
Tufia-haddad
Cathy-skinner
Digital-health
Product-development
Mayo-clinic-center
Mayo-clinic
Chief-science-officer
Medical-director
Nxgenport
கேத்தி-ஸ்கின்னர்

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.